Thomas P. Mcdonnell
No más puestos en curso
Perfil
Thomas P.
Mcdonnell worked as Vice President-US Marketing at Shire Plc from 2013 to 2015 and as Chief Commercial Officer at Neos Therapeutics, Inc. from 2015 to 2018.
He completed his undergraduate degree from Muhlenberg College.
Antiguos cargos conocidos de Thomas P. Mcdonnell.
Empresas | Cargo | Fin |
---|---|---|
NEOS THERAPEUTICS, INC. | Corporate Officer/Principal | 29/11/2018 |
SHIRE | Corporate Officer/Principal | 01/03/2015 |
Formación de Thomas P. Mcdonnell.
Muhlenberg College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas P. Mcdonnell